Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update.


Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
20 06 2023
Historique:
medline: 16 6 2023
pubmed: 19 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

To update the American Society of Clinical Oncology guideline on the management of anxiety and depression in adult cancer survivors. A multidisciplinary expert panel convened to update the guideline. A systematic review of evidence published from 2013-2021 was conducted. The evidence base consisted of 17 systematic reviews ± meta analyses (nine for psychosocial interventions, four for physical exercise, three for mindfulness-based stress reduction [MBSR], and one for pharmacologic interventions), and an additional 44 randomized controlled trials. Psychological, educational, and psychosocial interventions led to improvements in depression and anxiety. Evidence for pharmacologic management of depression and anxiety in cancer survivors was inconsistent. The lack of inclusion of survivors from minoritized groups was noted and identified as an important consideration to provide high-quality care for ethnic minority populations. It is recommended to use a stepped-care model, that is, provide the most effective and least resource-intensive intervention based on symptom severity. All oncology patients should be offered education regarding depression and anxiety. For patients with moderate symptoms of depression, clinicians should offer cognitive behavior therapy (CBT), behavioral activation (BA), MBSR, structured physical activity, or empirically supported psychosocial interventions. For patients with moderate symptoms of anxiety, clinicians should offer CBT, BA, structured physical activity, acceptance and commitment therapy, or psychosocial interventions. For patients with severe symptoms of depression or anxiety, clinicians should offer cognitive therapy, BA, CBT, MBSR, or interpersonal therapy. Treating clinicians may offer a pharmacologic regimen for depression or anxiety for patients who do not have access to first-line treatment, prefer pharmacotherapy, have previously responded well to pharmacotherapy, or have not improved following first-line psychological or behavioral management.Additional information is available at www.asco.org/survivorship-guidelines.

Identifiants

pubmed: 37075262
doi: 10.1200/JCO.23.00293
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3426-3453

Auteurs

Barbara L Andersen (BL)

The Ohio State University, Columbus, OH.

Christina Lacchetti (C)

American Society of Clinical Oncology, Alexandria, VA.

Jonathan S Berek (JS)

Stanford University School of Medicine, Palo Alto, CA.

Barry S Berman (BS)

Florida Cancer Specialists, West Palm Beach, FL.

Sage Bolte (S)

Inova Health Foundation, Falls Church, VA.

Don S Dizon (DS)

Legorreta Cancer Center at Brown University and Lifespan Cancer Institute, Providence, RI.

Barbara Given (B)

Michigan State University, East Lansing, MI.

Larissa Nekhlyudov (L)

Brigham and Women's Hospital, Boston, MA.
Dana-Farber Cancer Institute, Boston, MA.

William Pirl (W)

Dana-Farber Cancer Institute, Boston, MA.

Annette L Stanton (AL)

University of California, Los Angeles, Los Angeles, CA.

Julia H Rowland (JH)

Smith Center for Healing and the Arts, Washington, DC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH